Seven Eight Capital, LP Dexcom Inc Transaction History

Seven Eight Capital, LP

$927 Million
Q1 2024

A detailed history of Seven Eight Capital, LP transactions in Dexcom Inc stock. As of the latest transaction made, Seven Eight Capital, LP holds 5,102 shares of DXCM stock, worth $580,046. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,102

Previous 5,930 13.96%

Holding current value

$580,046

Previous $735,000 3.81%

% of portfolio

0.08%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$114.22 - $140.1 $94,574 - $116,002	-828 Reduced 13.96%	5,102 $707,000
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $1.37 Million - $2.26 Million	-18,204 Reduced 75.43%	5,930 $735,000
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $98,969 - $158,619	1,150 Added 5.0%	24,134 $2.25 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $846,899 - $986,279	7,530 Added 48.73%	22,984 $2.95 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $1.28 Million - $1.51 Million	12,324 Added 393.74%	15,454 $1.8 Million

Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $113,448 - $163,764	-1,335 Reduced 29.9%	3,130 $354,000
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $112,692 - $139,009	1,476 Added 49.38%	4,465 $360,000
Q2 2022 Aug 04, 2022	BUY	$67.99 - $132.89 $203,222 - $397,208	2,989 New	2,989 $223,000
Q2 2020 Aug 06, 2020	SELL	$62.68 - $105.34 $181,772 - $305,486	-2,900 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$47.79 - $75.63 $727,268 - $1.15 Million	-15,218 Reduced 83.99%	2,900 $781,000
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $663,481 - $1.04 Million	18,118 New	18,118 $3.96 Million
Q2 2019 Aug 12, 2019	SELL	$27.84 - $38.92 $498,837 - $697,368	-17,918 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $321,541 - $437,351	11,455 Added 177.24%	17,918 $2.13 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $1.28 Million - $1.78 Million	-47,600 Reduced 88.05%	6,463 $774,000
Q3 2018 Oct 18, 2018	SELL	$23.35 - $36.72 $249,845 - $392,904	-10,700 Reduced 16.52%	54,063 $7.73 Million
Q2 2018 Aug 07, 2018	BUY	$17.54 - $25.22 $780,530 - $1.12 Million	44,500 Added 219.61%	64,763 $6.15 Million
Q1 2018 May 14, 2018	BUY	$13.06 - $18.54 $264,634 - $375,676	20,263 New	20,263 $1.5 Million

Others Institutions Holding DXCM

# of Institutions

1,124

Shares Held

353M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $43.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account

Seven Eight Capital, LP Dexcom Inc Transaction History